Tumour cells maintain RET-ROS at a level that promotes proliferation by upregulating the glutathione system (GSH/GPx/GR, etc.)and its synergistic action with the thioredoxin system and NADPH regeneration pathway [35]. The gene discussed is RET; the disease is neoplasm.